OLIG2 and neoplasm: Immunostaining for markers of glial differentiation (GFAP and OLIG2) was mostly negative, with only a few PLAGL2-amplified tumors showing labeling of rare scattered tumor cells (Fig. 4, Supplementary Table S5).